A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.
about
VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesVTE Risk assessment - a prognostic Model: BATER Cohort Study of young womenComparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a community-based cohort studyPatients' understanding of genetic susceptibility testing in mainstream medicine: qualitative study on thrombophiliaClinical guidelines for testing for heritable thrombophilia.Factor V Leiden thrombophilia.Evidence-based approach to thrombophilia testing.Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.Laboratory thrombophilias and venous thromboembolism.Recurrent thrombotic occlusion of a transjugular intrahepatic portosystemic stent-shunt due to activated protein C resistanceHereditary and acquired thrombophilic disorders complicating vascular access in haemodialysis: O. Sarkar et alFactor V Leiden and venous thromboembolism: risk associated with hormone replacement therapy.Inherited thrombophilia and life-time risk of venous thromboembolism: is the burden reducible?Management of thrombophilia: who to screen?The measurement and application of thrombin generation.Issues concerning the laboratory investigation of inherited thrombophilia.Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patientsPharmacogenetic typing for oral anti-coagulant response among factor V Leiden mutation carriers.Impact of smoking during pregnancy on functional coagulation testingColon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutationEtiopathogenesis of Sheehan's Syndrome: Roles of Coagulation Factors and TNF-Alpha.Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk.Hormone therapies and venous thromboembolism: where are we now?Preventing thrombophilia-related complications of pregnancy: an update.Inherited risk factors for venous thromboembolism.Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysisAbsolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy.Genomic susceptibility-testing and pregnancy: something old, something new.Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster.A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives.Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture.Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis.Increased sperm count may account for high population frequency of factor V Leiden.A negative personal and family history for venous thrombotic events is not sufficient to exclude thrombophilia in patients with cerebral venous thrombosis.Genetic expressions of thrombophilic factors in patients with Sheehan's syndrome.
P2860
Q24632982-7EB6C666-75BB-4E02-B0B6-3DE75AE10EADQ24795738-282300C9-7DE2-494C-94A6-571264C917ABQ24815649-837A4D8D-8A8E-43AD-874D-E313C8F2F813Q28213173-73987082-7DD6-4A71-8A3D-355254971018Q34096556-FCFA94E7-A233-41A6-93CE-B8F74C8537EFQ34152374-86936ADA-5EE7-4375-A666-6C9B08CAD169Q34663749-B52A6A2F-3A1F-444B-8BF8-9D87D939660BQ34718108-7549E20E-3091-4BD1-A43A-DCCCB4563CF0Q34981644-1BC89734-1C61-4546-941D-82D44B8D7FA0Q35064544-8961017C-6BAB-4DAF-9D53-FBA660DF8932Q35574239-65A30CA0-8387-4197-993A-8153AFBCE9B7Q35579158-1D7CF256-258F-4FD6-8CA9-FF8A71B264DFQ35872936-E38339DC-42CF-4DB9-BF51-918F096359CCQ36030527-5FD33D2D-169F-4686-808E-34C1D5892A8CQ36237649-4B22AA1A-B6D4-4198-B5F5-7D77CC852D82Q36360383-5B71730B-D00E-47DE-AB38-3A959F6B6AF2Q36471056-90DCC96C-66CB-491E-8A3F-D476390AB20FQ36536307-0E0DD3BC-9967-4DD7-B68C-2E112F9E6E9EQ36851081-8A8F2803-D646-4C4C-80FA-3CF36B44F4DAQ37163228-FC197E51-FCFF-43AE-8E88-D6AD0E75F172Q37580200-0B58EDE5-2805-46AD-9196-4BF8E69B707AQ37730732-7A69E008-3E8E-4002-9300-9BD68D48B65EQ37777419-617978B1-3F62-46FA-B9D5-24DEDFBFEB0EQ37813184-70994896-22AD-493A-8E71-C135BE630A91Q38115587-F7FC3786-C80B-4BB5-B7FE-9122FEF28299Q38178063-3B7E6129-D155-45E6-B422-F8219DB1DD75Q42626063-7A66ECFD-6E37-4E99-9C96-9BBC35E6FCF9Q43934786-47628EBA-BFE0-4958-B24E-E86EAB6FA3B4Q47859948-A9F81FD8-FB77-40B8-8C81-63617CD1264EQ47906849-56774526-14B4-4860-8C85-18D7B57D9B98Q47973287-F0EA0F92-A11F-438C-914C-EC699B930D5FQ48560063-C3E870C8-DF20-404C-B071-2D8D18804EE3Q50754624-403E525F-7089-4A90-B630-7BE12866EC5FQ51795184-D74F4547-6C3D-4CDC-BDCE-84C06204D529Q52943650-2F700E10-4CBD-4911-9274-6BA2CD5DFC9FQ53060213-B6C660BD-A05E-4202-BF45-B3599C9BD101
P2860
A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A prospective study of asympto ...... nce of venous thromboembolism.
@en
A prospective study of asympto ...... nce of venous thromboembolism.
@nl
type
label
A prospective study of asympto ...... nce of venous thromboembolism.
@en
A prospective study of asympto ...... nce of venous thromboembolism.
@nl
prefLabel
A prospective study of asympto ...... nce of venous thromboembolism.
@en
A prospective study of asympto ...... nce of venous thromboembolism.
@nl
P2093
P1476
A prospective study of asympto ...... nce of venous thromboembolism.
@en
P2093
Hamulyák K
Koopman MM
Meinardi JR
Middeldorp S
van Der Meer J
van Pampus EC
P304
P356
10.7326/0003-4819-135-5-200109040-00008
P407
P577
2001-09-01T00:00:00Z